Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia.

Por Awad, A G
Publicado em 1997

Refractory Depression

Por Awad, A.G.
Publicado em 1992

Clinical Evaluation of Psychotropic Drugs for Psychiatric Disorders; Principles and Proposed Guidelines, Volume 2

Por Voruganti, L.N.P., Awad, A.G.
Publicado em 1994

The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.

Por Heslegrave, R J, Awad, A G, Voruganti, L N
Publicado em 1997

Quality of life measurement during antipsychotic drug therapy of schizophrenia.

Por Voruganti, L N, Heslegrave, R J, Awad, A G
Publicado em 1997

Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.

Por Awad, A G, Lapierre, Y D, Angus, C, Rylander, A
Publicado em 1997

Renal function in patients receiving long-term lithium therapy.

Por Uldall, P. R., Awad, A. G., McCormick, W. O., Carter, L. B., Gonsick, T., Grass, C. L., Kugelmass, M. I.
Publicado em 1981